We propose that vessel abnormalization limiting chemotherapeutic efficacy is driven by infiltrating and M2‐polarizing macrophages, which redistribute VEGF bio‐availability and alter its gradient in the tumor microenvironment. Here, VEGFA is linked to neoplasm.